Starling Oncology, Inc.(STLN)

Medical - Care Facilities · Cerritos, CA

$6.58+0.28 (+4.44%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T21:34:07.387Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:34:07.387Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -0.3
Quote price: 6.58

FMP input reference: ad03cc2eaddb42082332b148aee8d6851fa015397d59a0785f41cacae5aa3ea4

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

STLN Earnings Yield Metrics

EARNINGS YIELD

N/A

STLN Competitors' Earnings Yield

STLN

Starling Oncology, Inc.

Current

Market Cap

$657.89M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FDMT

4D Molecular Therapeutics, Inc.

vs STLN

Market Cap

$656.59M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANNX

Annexon, Inc.

vs STLN

Market Cap

$660.29M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HELP

Helus Pharma Inc.

vs STLN

Market Cap

$666.95M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXG

MiMedx Group, Inc.

vs STLN

Market Cap

$673.41M

Earnings Yield

0.87%

TTM Avg

4.56%

3Y Avg

4.76%

5Y Avg

4.76%

AURA

Aura Biosciences, Inc.

vs STLN

Market Cap

$638.20M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VSTM

Verastem, Inc.

vs STLN

Market Cap

$681.02M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLDB

Solid Biosciences Inc.

vs STLN

Market Cap

$681.27M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ZVRA

Zevra Therapeutics, Inc.

vs STLN

Market Cap

$634.30M

Earnings Yield

8.67%

TTM Avg

11.77%

3Y Avg

11.77%

5Y Avg

9.40%

PRME

Prime Medicine, Inc.

vs STLN

Market Cap

$632.16M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Starling Oncology, Inc. (STLN)	$657.89M	N/A	N/A	N/A	N/A
4D Molecular Therapeutics, Inc. (FDMT)vs ›	$656.59M	N/A	N/A	N/A	N/A
Annexon, Inc. (ANNX)vs ›	$660.29M	N/A	N/A	N/A	N/A
Helus Pharma Inc. (HELP)vs ›	$666.95M	N/A	N/A	N/A	N/A
MiMedx Group, Inc. (MDXG)vs ›	$673.41M	0.87%	4.56%	4.76%	4.76%
Aura Biosciences, Inc. (AURA)vs ›	$638.20M	N/A	N/A	N/A	N/A
Verastem, Inc. (VSTM)vs ›	$681.02M	N/A	N/A	N/A	N/A
Solid Biosciences Inc. (SLDB)vs ›	$681.27M	N/A	N/A	N/A	N/A
Zevra Therapeutics, Inc. (ZVRA)vs ›	$634.30M	8.67%	11.77%	11.77%	9.40%
Prime Medicine, Inc. (PRME)vs ›	$632.16M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

STLN Earnings Yield Metrics

STLN Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics